ICAD
ICAD Inc
Price:  
3.87 
USD
Volume:  
190,074.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-121.8%
Upside

As of 2025-09-19, the EV/EBITDA ratio of ICAD Inc (ICAD) is -17.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 86.28 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.98 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.6x - 11.1x 7.7x
Forward P/E multiples 4.6x - 14.3x 9.6x
Fair Price (0.11) - (1.29) (0.84)
Upside -102.9% - -133.3% -121.8%
3.87 USD
Stock Price
(0.84) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-16 -17.32
2025-07-15 -16.55
2025-07-14 -17.05
2025-07-11 -16.60
2025-07-10 -17.38
2025-07-09 -17.43
2025-07-08 -16.49
2025-07-07 -16.44
2025-07-03 -16.71
2025-07-02 -16.60
2025-07-01 -16.49
2025-06-30 -16.99
2025-06-27 -17.10
2025-06-26 -17.27
2025-06-25 -16.66
2025-06-24 -16.55
2025-06-23 -16.11